Endophthalmitis after intravitreal injections.
Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.
Schwartz
Stephen G
SG
University of Miami Miller School of Medicine, Bascom Palmer Eye Institute at Naples, Naples, FL 34102, USA. sschwartz2@med.miami.edu
Flynn
Harry W
HW
Scott
Ingrid U
IU
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D003030:Coagulase / Q000378:metabolism; D003937:Diagnosis, Differential; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007267:Injections / Q000009:adverse effects* / Q000592:standards; D013210:Staphylococcus / Q000201:enzymology / Q000302:isolation & purification / Q000502:physiology; D014221:Triamcinolone / Q000009:adverse effects; D014792:Visual Acuity; D014822:Vitreous Body / Q000382:microbiology / Q000473:pathology
D000900:Anti-Bacterial Agents; D003030:Coagulase; D014221:Triamcinolone